A detailed history of Nomura Holdings Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Nomura Holdings Inc holds 40,288 shares of MRK stock, worth $3.95 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
40,288
Previous 62,105 35.13%
Holding current value
$3.95 Million
Previous $7.69 Million 40.49%
% of portfolio
0.01%
Previous 0.02%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$111.15 - $128.97 $2.42 Million - $2.81 Million
-21,817 Reduced 35.13%
40,288 $4.58 Million
Q2 2024

Aug 14, 2024

BUY
$123.8 - $132.96 $621,228 - $667,193
5,018 Added 8.79%
62,105 $7.69 Million
Q1 2024

May 15, 2024

BUY
$113.24 - $131.95 $6.46 Million - $7.53 Million
57,087 New
57,087 $7.53 Million
Q4 2023

Feb 14, 2024

BUY
$100.18 - $109.02 $5.84 Million - $6.36 Million
58,297 New
58,297 $6.36 Million
Q2 2023

Aug 14, 2023

BUY
$108.61 - $118.38 $7.7 Million - $8.39 Million
70,889 New
70,889 $8.18 Million
Q4 2022

Feb 14, 2023

SELL
$87.44 - $112.11 $2.08 Million - $2.67 Million
-23,797 Reduced 95.42%
1,142 $125,000
Q3 2022

Nov 15, 2022

SELL
$84.53 - $94.96 $37.9 Million - $42.6 Million
-448,874 Reduced 94.74%
24,939 $2.18 Million
Q2 2022

Aug 15, 2022

BUY
$83.49 - $94.64 $31.8 Million - $36.1 Million
381,108 Added 411.1%
473,813 $43.8 Million
Q1 2022

May 18, 2022

BUY
$73.51 - $82.4 $5.75 Million - $6.44 Million
78,160 Added 537.37%
92,705 $7.81 Million
Q4 2021

Feb 14, 2022

SELL
$72.28 - $90.54 $441,341 - $552,837
-6,106 Reduced 29.57%
14,545 $1.14 Million
Q3 2021

Nov 15, 2021

SELL
$71.68 - $78.83 $2.93 Million - $3.22 Million
-40,854 Reduced 66.42%
20,651 $1.67 Million
Q2 2021

Aug 16, 2021

BUY
$70.31 - $77.77 $2.84 Million - $3.14 Million
40,437 Added 191.94%
61,505 $4.76 Million
Q1 2021

May 17, 2021

SELL
$68.86 - $81.11 $40 Million - $47.1 Million
-580,258 Reduced 96.5%
21,068 $1.61 Million
Q4 2020

Feb 16, 2021

BUY
$71.77 - $79.65 $26.1 Million - $28.9 Million
363,218 Added 152.54%
601,326 $49 Million
Q3 2020

Nov 12, 2020

BUY
$73.18 - $82.95 $11.6 Million - $13.2 Million
158,993 Added 200.96%
238,108 $19.6 Million
Q2 2020

Aug 14, 2020

BUY
$70.42 - $80.13 $1.87 Million - $2.13 Million
26,574 Added 50.58%
79,115 $6.09 Million
Q1 2020

May 15, 2020

BUY
$63.36 - $87.82 $3.33 Million - $4.61 Million
52,541 New
52,541 $4 Million
Q1 2020

May 14, 2020

SELL
$63.36 - $87.82 $35.4 Million - $49 Million
-558,267 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$77.58 - $87.54 $18.9 Million - $21.3 Million
-243,638 Reduced 30.38%
558,267 $50 Million
Q3 2019

Nov 14, 2019

BUY
$76.08 - $82.93 $44.1 Million - $48 Million
579,388 Added 260.38%
801,905 $67.1 Million
Q2 2019

Aug 14, 2019

BUY
$69.84 - $81.59 $11.6 Million - $13.6 Million
166,609 Added 298.01%
222,517 $18.8 Million
Q1 2019

May 14, 2019

BUY
$69.58 - $79.36 $2.96 Million - $3.37 Million
42,520 Added 317.6%
55,908 $4.57 Million
Q4 2018

Feb 14, 2019

SELL
$65.24 - $75.71 $36.9 Million - $42.8 Million
-565,165 Reduced 97.69%
13,388 $1.01 Million
Q3 2018

Nov 14, 2018

BUY
$57.69 - $67.84 $8.93 Million - $10.5 Million
154,759 Added 36.52%
578,553 $41.2 Million
Q2 2018

Aug 14, 2018

SELL
$50.83 - $59.72 $64.2 Million - $75.4 Million
-1,262,681 Reduced 74.87%
423,794 $18.7 Million
Q1 2018

May 14, 2018

SELL
$50.96 - $59.23 $36 Million - $41.8 Million
-706,552 Reduced 29.53%
1,686,475 $91.9 Million
Q1 2018

May 14, 2018

BUY
$50.96 - $59.23 $85.9 Million - $99.9 Million
1,686,475 Added 238.69%
2,393,027 $150 Million
Q4 2017

Feb 14, 2018

BUY
$51.62 - $61.64 $2.47 Million - $2.95 Million
47,884 Added 7.27%
706,552 $58.6 Million
Q3 2017

Nov 14, 2017

BUY
$58.67 - $63.13 $38.6 Million - $41.6 Million
658,668
658,668 $42.2 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $248B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Nomura Holdings Inc Portfolio

Follow Nomura Holdings Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Holdings Inc with notifications on news.